MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LFMD had -$12,442,534 decrease in cash & cash equivalents over the period. -$944,394 in free cash flow.

Cash Flow Overview

Change in Cash
-$12,442,534
Free Cash flow
-$944,394
Unit: Dollar
Positive Cash Flow Breakdown
    • Sale of common stock under atm, ...
    • Accrued expenses
    • Stock compensation expense
    • Others
Negative Cash Flow Breakdown
    • Repayment of debt instruments
    • Accounts payable
    • Net loss
    • Others

Cash Flow
2025-09-30
2025-06-30
Net loss
-4,670,027 346,850
Amortization of debt discount
33,481 200,888
Amortization of capitalized software
2,459,534 4,627,520
Amortization of intangibles
269,450 505,888
Loss on debt extinguishment
-1,155,851 -
Accretion of consideration payable
-0
Depreciation of fixed assets
262,747 346,822
Noncash operating lease expense
243,915 577,689
Stock compensation expense
3,198,036 4,643,142
Accounts receivable
-722,079 -887,684
Product deposit
119,518 210,237
Inventory
181,027 453,997
Other current assets
1,287,639 -707,257
Operating lease liabilities
-49,673 -198,901
Deferred revenue
-2,579,515 -2,690,893
Accounts payable
-4,738,135 8,283,386
Accrued expenses
5,133,305 -5,865,264
Net cash provided by operating activities
-147,136 11,707,834
Cash paid for capitalized software costs
2,797,222 5,648,965
Purchase of equipment
797,258 917,956
Purchase of intangible assets
-0
Net cash used in investing activities
-3,594,480 -6,566,921
Repayment of notes payable, net of prepayment penalty
-0
Repayment of debt instruments
16,667,433 2,052,288
Sale of common stock under atm, net
8,721,717 -
Preferred stock dividends
776,563 1,553,125
Cash proceeds from exercise of warrants
464,950 -
Cash proceeds from exercise of options
5,950 0
Contingent consideration payments for resumebuild acquisition
-0
Distributions to non-controlling interest
449,539 312,119
Net cash used in financing activities
-8,700,918 -3,917,532
Net (decrease) increase in cash
-12,442,534 1,223,381
Cash and cash equivalents at beginning of period
35,004,924 -
Cash and cash equivalents at end of period
23,785,771 -
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net (decrease)increase in cash-$12,442,534 Sale of common stockunder atm, net$8,721,717 Cash proceeds fromexercise of warrants$464,950 Cash proceeds fromexercise of options$5,950 Accrued expenses$5,133,305 Stock compensationexpense$3,198,036 Amortization of capitalizedsoftware$2,459,534 Loss on debtextinguishment-$1,155,851 Accounts receivable-$722,079 Amortization of intangibles$269,450 Depreciation of fixed assets$262,747 Noncash operating leaseexpense$243,915 Amortization of debt discount$33,481 Net cash used infinancing activities-$8,700,918 Net cash used ininvesting activities-$3,594,480 Net cash provided byoperating activities-$147,136 Canceled cashflow$9,192,617 Canceled cashflow$13,478,398 Repayment of debtinstruments$16,667,433 Cash paid forcapitalized software costs$2,797,222 Purchase of equipment$797,258 Accounts payable-$4,738,135 Preferred stock dividends$776,563 Distributions tonon-controlling interest$449,539 Net loss-$4,670,027 Deferred revenue-$2,579,515 Other current assets$1,287,639 Inventory$181,027 Product deposit$119,518 Operating leaseliabilities-$49,673

LifeMD, Inc. (LFMD)

LifeMD, Inc. (LFMD)